All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
220480AB3 / Amrn 3.5 1/32 Bond
|
|
|
|
|
|
|
|
US189464AB64 / Clovis Oncology, Inc. 2.5% 9/15/2021
|
|
|
|
|
|
|
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
DMTX / Dimension Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
PTN / Palatin Technologies, Inc.
|
|
|
|
|
|
|
|
CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
ECYT / Endocyte, Inc.
|
|
|
|
|
|
|
|
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
|
|
|
|
|
|
|
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
98411CAB6 / XenoPort, Inc. Bonds 2.5% 2/1/2022
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
SELB / Selecta Biosciences Inc
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
IMDZ / Immune Design Corp.
|
|
|
|
|
|
|
|
451731103 / Ignyta, Inc.
|
|
|
|
|
|
|
|
MDWD / MediWound Ltd.
|
|
|
|
|
|
|
|
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
AAAP / Advanced Accelerator Applications S.A
|
|
|
|
|
|
|
|
FMI / Foundation Medicine, Inc.
|
|
|
|
|
|
|
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GNMX / Aevi Genomic Medicine, Inc.
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
JUNO / Juno Therapeutics, Inc.
|
|
|
|
|
|
|
|
OSIR / Osiris Therapeutics, Inc.
|
|
|
|
|
|
|
|
US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
30161QAC8 / Exelixis, Inc. Bond
|
|
|
|
|
|
|
|
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
|
|
|
|
|
|
|
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
STML / Stemline Therapeutics, Inc.
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
|
|
|
|
|
|
|
|
ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
CYTR / LadRx Corp
|
|
|
|
|
|
|
|
ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ACOR / Acorda Therapeutics, Inc.
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
NVIV / InVivo Therapeutics Holdings Corp.
|
|
|
|
|
|
|
|
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
NBRV / Nabriva Therapeutics Plc
|
|
|
|
|
|
|
|
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
CERS / Cerus Corporation
|
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
0HBB / Aimmune Therapeutics Inc
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
|
|
|
|
|
|
|
|
TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
MCRB / Seres Therapeutics, Inc.
|
|
|
|
|
|
|
|
/ Achaogen Inc
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
QLGN / Qualigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|